HW
MRNA icon

Hancock Whitney’s Moderna MRNA Stock Holding History

Hancock Whitney’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,044
Closed -$3.04M – 638
2023
Q2 		$3.04M Sell
25,044
-5,025
-17% -$670K 0.12% 145
2023
Q1 		$4.62M Sell
30,069
-1,699
-5% -$280K 0.19% 109
2022
Q4 		$5.71M Buy
31,768
+717
+2% +$117K 0.22% 98
2022
Q3 		$3.67M Buy
+31,051
New +$4.71M 0.16% 120

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Hancock Whitney's MRNA Position: Q3 2023 in Review

Hancock Whitney sold out of Moderna (MRNA) in Q3 2023, closing a stake of 25,044 shares — an estimated $3.04M sold.

Hancock Whitney first reported a position in MRNA in Q3 2022 and held it in 4 quarters. The position peaked at $5.71M in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Hancock Whitney reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Hancock Whitney sold 25,044 Moderna shares in Q3 2023, an estimated $3.04M.
  • Hancock Whitney first reported a position in Moderna in Q3 2022 and held it in 4 quarters.
  • Hancock Whitney's Moderna position peaked at $5.71M in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Hancock Whitney's 13F filing for Q3 2023, filed 13 Nov 2023.